News

This nonhormonal hot-flash remedy gives options to women, experts say
Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
Flow Space on MSN3d
Can This FDA-Approved Drug Tame Hot Flashes and Menopause Belly?
When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.
Fierce Pharma3d
Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease
Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...
US FDA approves Alcon's new dry-eye drug
Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).
Pharmaceutical Technology on MSN3d
FDA approves Eton’s application for hydrocortisone oral solution
Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and ...
FDA approves topical foam for plaque psoriasis of the scalp and body
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...